genedrive (LON:GDR) Stock Price Crosses Below Fifty Day Moving Average – Here’s Why

Shares of genedrive plc (LON:GDRGet Free Report) passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 2.21 ($0.03) and traded as low as GBX 2 ($0.03). genedrive shares last traded at GBX 2 ($0.03), with a volume of 3,627,680 shares trading hands.

genedrive Price Performance

The company has a debt-to-equity ratio of 0.35, a quick ratio of 5.52 and a current ratio of 4.60. The stock has a market capitalization of £11.36 million, a price-to-earnings ratio of -0.56 and a beta of -0.04. The company has a 50 day moving average of GBX 2.21 and a 200 day moving average of GBX 2.36.

genedrive (LON:GDRGet Free Report) last released its quarterly earnings results on Friday, November 29th. The company reported GBX (4.70) (($0.06)) earnings per share for the quarter. genedrive had a negative return on equity of 191.22% and a negative net margin of 1,412.18%. As a group, equities research analysts anticipate that genedrive plc will post 209.9999867 EPS for the current year.

Insider Buying and Selling

In other genedrive news, insider Ian David Gilham purchased 225,000 shares of the business’s stock in a transaction on Friday, December 20th. The stock was purchased at an average price of GBX 2 ($0.03) per share, for a total transaction of £4,500 ($5,663.94). 14.75% of the stock is owned by corporate insiders.

About genedrive

(Get Free Report)

ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.

See Also

Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.